Spaces:
Running
Running
Upload sample_docs/discharge_summary_001.txt
Browse files
sample_docs/discharge_summary_001.txt
ADDED
|
@@ -0,0 +1,42 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
DISCHARGE SUMMARY
|
| 2 |
+
Patient: John D. (MRN: 00123)
|
| 3 |
+
Date of Admission: 2026-05-28
|
| 4 |
+
Date of Discharge: 2026-06-02
|
| 5 |
+
Attending Physician: Dr. Sarah Patel, MD
|
| 6 |
+
|
| 7 |
+
PRIMARY DIAGNOSIS:
|
| 8 |
+
Community-acquired pneumonia (CAP), right lower lobe.
|
| 9 |
+
|
| 10 |
+
SECONDARY DIAGNOSES:
|
| 11 |
+
- Type 2 Diabetes Mellitus (controlled)
|
| 12 |
+
- Hypertension
|
| 13 |
+
|
| 14 |
+
HOSPITAL COURSE:
|
| 15 |
+
Mr. D. is a 62-year-old male who presented to the ED with a 4-day history of productive cough,
|
| 16 |
+
fever (T 38.9°C), and shortness of breath. Chest X-ray confirmed right lower lobe consolidation.
|
| 17 |
+
Blood cultures were drawn and sputum cultures sent. He was started on IV Ceftriaxone 1g q24h
|
| 18 |
+
and Azithromycin 500mg daily. Repeat chest X-ray on Day 3 showed improvement. He was
|
| 19 |
+
transitioned to oral Amoxicillin-Clavulanate 875mg/125mg BID on Day 4 and tolerated well.
|
| 20 |
+
His blood glucose was monitored closely given his diabetic history; insulin sliding scale was used.
|
| 21 |
+
He remained afebrile for 48 hours prior to discharge.
|
| 22 |
+
|
| 23 |
+
MEDICATIONS AT DISCHARGE:
|
| 24 |
+
1. Amoxicillin-Clavulanate 875mg/125mg — 1 tablet by mouth twice daily × 5 more days
|
| 25 |
+
2. Metformin 1000mg — 1 tablet by mouth twice daily (home medication)
|
| 26 |
+
3. Lisinopril 10mg — 1 tablet by mouth once daily (home medication)
|
| 27 |
+
4. Aspirin 81mg — 1 tablet by mouth once daily (home medication)
|
| 28 |
+
|
| 29 |
+
ALLERGIES:
|
| 30 |
+
Penicillin — rash (mild). NOTE: Patient was given Amoxicillin-Clavulanate under observation;
|
| 31 |
+
no adverse reaction observed during admission.
|
| 32 |
+
|
| 33 |
+
FOLLOW-UP:
|
| 34 |
+
- Primary Care (Dr. Patel): 1 week post-discharge — June 9, 2026
|
| 35 |
+
- Pulmonology consult if symptoms recur
|
| 36 |
+
|
| 37 |
+
DISCHARGE INSTRUCTIONS:
|
| 38 |
+
- Complete the full antibiotic course.
|
| 39 |
+
- Rest and increase fluid intake.
|
| 40 |
+
- Return to ED if fever > 38.5°C, worsening shortness of breath, or hemoptysis.
|
| 41 |
+
- Monitor blood glucose twice daily; target fasting glucose 80–130 mg/dL.
|
| 42 |
+
- Do not drive while on any sedating medications.
|